1 It is unknown how cardiac stimulation by Ca 2+ sensitization modulates the cardiovascular response to exercise when left ventricular (LV) function is chronically depressed following a myocardial infarction. We therefore investigated the eects of EMD 57033 at rest and during exercise and compared these to those of the mixed Ca 2+ -sensitizer/phosphodiesterase-III inhibitor pimobendan. 2 Pigs were chronically instrumented for measurement of cardiovascular performance. At the time of instrumentation, infarction was produced by coronary artery ligation (MI, n=12). Studies in MI were performed in the awake state, 2 ± 3 weeks after infarction. 3 MI were characterized by a lower resting cardiac output (18%), stroke volume (30%) and LVdP/ dt max (18%), and a doubling of LV end-diastolic pressure, compared to normal pigs (N, n=13). 4 In 11 resting MI, intravenous EMD 57033 (0.2 ± 0.8 mg kg 71 min
71) increased LVdP/dt max (57+5%) and stroke volume (26+6%) with no eect on heart rate, LV ®lling pressure, and myocardial O 2 -consumption, similar to N. 5 In MI, the eects of EMD 57033 (0.4 mg kg 71 min
71, IV) on stroke volume and LVdP/dt max were maintained during treadmill exercise up to 85% of maximal heart rate, while heart rate was lower compared to control exercise (all P50.05). In contrast, the eects of EMD57033 gradually waned in N at increasing intensity of exercise. 6 Compared to N, the cardiostimulatory eects of pimobendan (20 mg kg 71 min
71, IV) were blunted in MI both at rest and during exercise compared to N. 7 In conclusion, the positive inotropic actions of the Ca 2+ sensitizer EMD 57033 are unmitigated in resting and exercising MI compared to N, while those of the mixed Ca 2+ -sensitizer/ phosphodiesterase-III inhibitor pimobendan are blunted.